Natco Pharma Q1 Results
- BSE: 524816
- NSE: NATCOPHARM
- ISIN: INE987B01026
- Sector: Biotechnology & Drugs
BSE
908.90
-2.60 (-0.29%)
-2.60 (-0.29%)Volume36.28 K
Updated: Tue 11 Aug, 2026 | 15:29:54
NSE
907.00-3.50 (-0.38%)
-3.50 (-0.38%)Volume4.06 L
Updated: Tue 11 Aug, 2026 | 15:51:12
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Natco Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 815.50 | 661.90 | 5.74% | 601.90 | 35.49% |
| Depreciation/ Amortization | 57.60 | 50.40 | -41.40% | 44.10 | 30.61% |
| Operating Income | 513.40 | 77.20 | 14.14% | 760.70 | -32.51% |
| Net Income | 480.70 | 267.90 | 18.22% | 668.50 | -28.09% |
| Other Operating Expenses Total | 355.90 | 298.30 | 34.66% | 235.60 | 51.06% |
| Net Income Before Taxes | 571.90 | 144.10 | 13.05% | 803.60 | -28.83% |
| Total Revenue | 1,328.90 | 739.10 | 8.84% | 1,362.60 | -2.47% |
| Selling/ General/ Admin Expenses Total | 169.00 | 158.50 | 6.02% | 142.00 | 19.01% |
| Diluted Normalized EPS | 26.84 | 14.96 | 18.22% | 37.32 | -28.08% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.